Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

0.6400

+0.0310 (5.09%)

At close: Aug 25, 2026, 4:00 PM EDT

0.6433

+0.0033 (0.52%)

After-hours: Aug 25, 2026, 7:58 PM EDT

Outlook Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	-	8.08	14.93	23.39	17.4	14.48
Cash & Short-Term Investments	7.75	8.08	14.93	23.39	17.4	14.48
Cash Growth	-12.95%	-45.85%	-36.19%	34.46%	20.17%	15.49%
Accounts Receivable	-	1.49	-	-	-	-
Receivables	-	1.49	-	-	-	-
Inventory	-	3.34	-	-	-	-
Prepaid Expenses	-	4.48	12.49	7.59	10.12	7.03
Total Current Assets	-	17.39	27.42	30.98	27.52	21.51
Property, Plant & Equipment	-	0.23	0.27	0.03	0.07	0.28
Long-Term Investments	-	0.55	0.69	0.79	0.8	0.85
Long-Term Deferred Charges	-	0.28	-	-	0.12	-
Other Long-Term Assets	-	0.14	0.44	0.5	0.01	0.17
Total Assets	-	18.58	28.82	32.3	28.53	22.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	-	10.19	7.97	6.57	3.49	2.2
Accrued Expenses	-	5.31	3.24	2.75	3.43	1.73
Current Portion of Long-Term Debt	-	29.95	29.44	35.55	10.92	0.9
Current Portion of Leases	-	0.06	0.05	0	0.04	0.07
Current Income Taxes Payable	-	0.3	1.86	1.86	1.86	1.86
Total Current Liabilities	-	45.81	42.55	46.73	19.73	6.75
Long-Term Debt	-	-	-	-	-	10.89
Long-Term Leases	-	0.19	0.25	-	0	0.04
Other Long-Term Liabilities	-	4.77	59.1	0.01	0.06	0.52
Total Liabilities	-	50.77	101.9	46.74	19.79	18.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	-	0.54	0.24	0.13	2.27	1.76
Additional Paid-In Capital	-	572.98	469.97	453.35	415.4	345.73
Retained Earnings	-	-605.71	-543.28	-467.92	-408.94	-342.88
Total Common Equity	-28.99	-32.19	-73.08	-14.44	8.74	4.61
Shareholders' Equity	-28.99	-32.19	-73.08	-14.44	8.74	4.61
Total Liabilities & Equity	-	18.58	28.82	32.3	28.53	22.81

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	27.19	30.19	29.74	35.56	10.96	11.9
Net Cash (Debt)	-19.44	-22.11	-14.81	-12.16	6.44	2.57
Net Cash Growth	-	-	-	-	150.06%	-66.60%
Net Cash Per Share	-0.24	-0.64	-0.80	-0.97	0.61	0.34
Filing Date Shares Outstanding	136.74	64.11	24.91	13.01	11.41	11.21
Total Common Shares Outstanding	136.74	53.89	23.91	13.01	11.37	8.82
Working Capital	-	-28.43	-15.14	-15.75	7.79	14.76
Book Value Per Share	-0.28	-0.60	-3.06	-1.11	0.77	0.52
Tangible Book Value	-28.99	-32.19	-73.08	-14.44	8.74	4.61
Tangible Book Value Per Share	-0.28	-0.60	-3.06	-1.11	0.77	0.52
Machinery	-	-	-	-	-	1.07

SEC Filings: 10-K · 10-Q